Grants and Contributions:
Title:
Inflammation – biomarkers of health, aging, stress and fatigue, and anti-inflammatory cannabis formulations
Agreement Number:
1039059
Agreement Value:
$176,000.00
Agreement Date:
Oct 1, 2025 - Mar 17, 2027
Description:
Pathway Rx is engaged in the development of natural based pharmaceutical products for prevention and treatment of inflammation.
Organization:
National Research Council Canada
Expected Results:
The expected results and outcomes of NRC Industrial Research Assistance Program is focused on growing small and medium-sized enterprises (SMEs) through innovation and wealth creation for Canada.
Location:
Calgary, Alberta, CA T3H 4Z2
Reference Number:
172-2025-2026-Q4-1039059
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
725412480
Recipient Type:
For-profit organization
Recipient's Legal Name:
Pathway Rx Inc.
Federal Riding Name:
Calgary Signal Hill
Federal Riding Number:
48012
Program:
Industrial Research Assistance Program
Program Purpose:
The purpose of Industrial Research Assistance Program Contributions to Firms is to provide support that assists small and medium-sized enterprises (SMEs) to advance their innovation knowledge and ability to innovate, grow through innovation and stimulate wealth creation for Canada.
Coverage:
Industrial Research Assistance Program projects stimulate wealth creation for Canada through technological innovation and strengthen Canadian innovation ecosystem by creating new industrial capacity.
NAICS Code:
62151